These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7850014)

  • 1. Reduction in goiter size by 131I therapy in patients with non-toxic multinodular goiter.
    Wesche MF; Tiel-v-Buul MM; Smits NJ; Wiersinga WM
    Eur J Endocrinol; 1995 Jan; 132(1):86-7. PubMed ID: 7850014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
    Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine therapy for multinodular toxic goiter.
    Nygaard B; Hegedüs L; Ulriksen P; Nielsen KG; Hansen JM
    Arch Intern Med; 1999 Jun; 159(12):1364-8. PubMed ID: 10386513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can radioactive iodine be used in the treatment of diffuse non-toxic goiter?].
    Nygaard B; Hegedüs L; Bennedbaek FN; Veje A; Faber JO; Hansen JE
    Ugeskr Laeger; 1998 Sep; 160(37):5349-52. PubMed ID: 9748860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine treatment of multinodular non-toxic goitre.
    Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Søe-Jensen P; Hansen JM
    BMJ; 1993 Oct; 307(6908):828-32. PubMed ID: 8401123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid volume and function after 131I treatment of diffuse non-toxic goitre.
    Nygaard B; Farber J; Veje A; Hansen JE
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):493-6. PubMed ID: 9196613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
    Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 131I therapy of toxic and non-toxic goiters.
    Beckers C
    Q J Nucl Med; 1999 Dec; 43(4):291-6. PubMed ID: 10731779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function.
    Bonnema SJ; Bertelsen H; Mortensen J; Andersen PB; Knudsen DU; Bastholt L; Hegedüs L
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3636-41. PubMed ID: 10523007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)].
    Pisarek M; Baczyk M; Gryczyńska M; Sowiński J
    Endokrynol Pol; 2007; 58(1):18-26. PubMed ID: 17354201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonographic versus scintigraphic measurement of thyroid volume in patients referred for 131I therapy.
    Wesche MF; Tiel-van Buul MM; Smits NJ; Wiersinga WM
    Nucl Med Commun; 1998 Apr; 19(4):341-6. PubMed ID: 9853324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine for nontoxic multinodular goiter.
    Huysmans D; Hermus A; Edelbroek M; Barentsz J; Corstens F; Kloppenborg P
    Thyroid; 1997 Apr; 7(2):235-9. PubMed ID: 9133693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed 30 mCi 131I-iodine therapy without recombinant human thyroid-stimulating hormone stimulation as an attractive therapeutic alternative in nontoxic nodular goiter.
    Riguetto CM; Miguel VP; Pavin EJ; Amorim BJ; Ramos CD; Zantut-Wittmann DE
    Nucl Med Commun; 2020 Aug; 41(8):727-732. PubMed ID: 32427701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoimmunization and multinodular large toxic goiter therapy using repeated doses of 131I].
    Pisarek M; Baczyk M; Gryczyńska M; Pietz L; Ziemnicka K; Sowiński J
    Pol Arch Med Wewn; 2006 Jun; 115(6):545-50. PubMed ID: 17263226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone.
    Paz-Filho GJ; Mesa-Junior CO; Olandoski M; Woellner LC; Goedert CA; Boguszewski CL; Carvalho GA; Graf H
    Braz J Med Biol Res; 2007 Dec; 40(12):1661-70. PubMed ID: 17934635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term effect of 131I therapy of multinodular non-toxic goiter].
    Nygaard B; Hegedüs L; Gervil M; Jensen HH; Søe-Jensen P; Hansen JE
    Ugeskr Laeger; 1994 Sep; 156(39):5699-703. PubMed ID: 7985257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
    Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
    Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard dose 131I therapy for toxic multinodular goiter in an endemic goiter region.
    Gonçalves E; Castro JA; Gross JL
    Braz J Med Biol Res; 1986; 19(6):723-9. PubMed ID: 3651625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.